YonaLink, a Boston, MA-based clinical trial software provider, raised $6M in funding.
The round, led by Debiopharm Innovation Fund, was co-funded by the European Union. It also included Israel’s eHealth Ventures.
The company intends to use the funds to expand its team and platform’s capabilities, also drive its adoption among clinical trial sponsors and their clinical research organization (CRO) partners.
Led by CEO Iddo Peleg, YonaLink equips research teams with the ability to extract up-to-date patient data from an EHR and stream that data into a clinical trial electronic data capture (EDC) system in real time. Headquartered in Boston with R&D operations in Israel, the company’s SaaS platform has the capabilities to stream up-to-date data from any clinical site’s EHR platform, and populate it within YonaLink’s EDC or other data capture systems. With built-in eConsent and ePRO / eCOA and streaming EHR-to-EDC capabilities, its EDC provides a comprehensive solution for today’s clinical trial needs, bringing EDC and eSource functionality together in a single tool.
FinSMEs
10/11/2022